The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread
A gB/MF59 vaccine candidate for human cytomegalovirus (HCMV) provided partial protection in organ transplant patients. Here, the authors identify antibody responses in trial participants that target virally infected cells to control cell-to-cell spread of HCMV, providing a potential mechanism for th...
Main Authors: | A. C. Gomes, I. A. Baraniak, A. Lankina, Z. Moulder, P. Holenya, C. Atkinson, G. Tang, T. Mahungu, F. Kern, P. D. Griffiths, M. B. Reeves |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-36683-x |
Similar Items
-
Epitope-specific humoral responses to human cytomegalovirus glycoprotein-B vaccine with MF59: Anti-AD2 levels correlate with protection from viremia
by: Baraniak, Ilona, et al.
Published: (2018) -
AS03- and MF59-adjuvanted influenza vaccines in children
by: Wilkins, A, et al.
Published: (2017) -
A temperature-dependent virus-binding assay reveals the presence of neutralising antibodies in human cytomegalovirus gB vaccine recipients’ sera
by: Gomes, Ariane, et al.
Published: (2023) -
Immunology and efficacy of MF59-adjuvanted vaccines
by: Eun-Ju Ko, et al.
Published: (2018-12-01) -
Development of MF-59 adjuvant using chitosan derivatives to influenza vaccine
by: Alireza Loghmani, et al.
Published: (2020-06-01)